|
Volumn 35, Issue 3, 2010, Pages 213-
|
What is the clinical significance of the findings from the delayed-start trial of rasagiline in Parkinson's disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
RASAGILINE;
CLINICAL TRIAL;
DAILY LIFE ACTIVITY;
DISEASE COURSE;
HUMAN;
LETTER;
MENTAL FUNCTION;
MOTOR PERFORMANCE;
NEUROPROTECTION;
PARKINSON DISEASE;
UNIFIED PARKINSON DISEASE RATING SCALE;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INDANS;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
|
EID: 77958053600
PISSN: 02515350
EISSN: None
Source Type: Journal
DOI: 10.1159/000313554 Document Type: Letter |
Times cited : (2)
|
References (8)
|